Language / La langue: 
Les infections

Dr. Christine Maheu, RN, PhD

Dr. Christine Maheu is an Associate Professor in the Ingram School of Nursing, Faculty of Medicine, McGill University. Dr. Maheu is also an Affiliate Scientist at the University Health Network and the University of Toronto. At McGill University, she teaches research methods, supervises graduate students (masters, doctoral, post-doctoral), mentors practicing nurses and students in research, and conducts research in English and French. She has held research awards with the Canadian Institutes of Health Research, the Canadian Cancer Society, and the Canadian Partnership Against Cancer. These awards funded her research in psychosocial oncology, which focuses on developing and testing psychosocial interventions or measurements tools for various cancer populations. Additionally, in partnership with Ipsos Canada and funded by the Canadian Partnership Against Cancer, she is co-leading a nationwide survey of the needs of cancer patients for transition care from the end of their treatment to three years after their diagnosis. Dr. Maheu received awards for excellence in nursing research (2013, 2015, 2016) from Ovarian Cancer Canada, the Canadian Association of Nurses in Oncology, and the Quebec Association of Nurses in Oncology.

View all Cancer and Work team members

Ms. Rosemary Cashman

Ms. Rosemary Cashman is a nurse practitioner at the BC Cancer Agency and an Adjunct Professor in the Faculty of Nursing at the University of British Columbia. Her professional experience includes the care of lymphoma, lung cancer and brain cancer patients. She co-chairs the Patient and Family Advisory Council, which guides the brain tumour care program at the BC Cancer Agency. She has authored book chapters and articles related to the care of brain tumour patients and their families. Ms. Cashman was involved in developing and implementing a rapid-access radiotherapy clinic for the palliative treatment of lung cancer and she continues to work in this clinic.

View all advisory board members and expert writers

Kyla Johnson, Occupational Therapist, Segal Cancer Centre, Jewish General Hospital

Ms. Kyla Johnson, M.Sc.A., originally from Edmonton, Alberta, Kyla Johnson works as an Occupational Therapist at the Segal Cancer Center of the Jewish General Hospital. She holds a Master of Science in Occupational Therapy from McGill University. Her goal as a rehabilitation professional in Oncology is to enable people with cancer to be able to do what they want and need to do, in all stages of their cancer experience. Kyla helps develop strategies and accommodations to facilitate a return to meaningful life roles, including work. She is specialized in cancer-related cognitive dysfunction and runs a weekly group teaching strategies to improve daily cognitive functioning. Kyla also leads a volunteer yoga class for young adults with cancer. She lives in Montreal, Quebec.

View all advisory board members and expert writers

Ms. Maureen Parkinson, Vocational Rehabilitation Counsellor, M.Ed. C.C.R.C, BC Cancer

Ms. Maureen Parkinson is the province-wide vocational rehabilitation counsellor at the BC Cancer Agency. She has also been vocational rehabilitation counsellor at a public rehabilitation hospital and vocational rehabilitation consultant to insurance companies and the court system. She has instructed and facilitated Service-Canada-funded programs on job searching and career exploration. Ms. Parkinson has a Masters in Counselling Psychology, is a Canadian Certified Rehabilitation Counsellor, and completed the Certified Return to Work Coordinator Program through the National Institute for Disability Management and Research. She has developed return-to-work and job-search seminars for cancer patients and created the guidebook “Cancer and Returning to Work: A Practical Guide for Cancer Patients” as well as on-line articles about returning to work and school. She also co-authored a paper commissioned by the Canadian Association of Psychosocial Oncology, “Cancer and Work: A Canadian Perspective”.

View all Cancer and Work team members

Il arrive que le cancer et les traitements associés réduisent l’efficacité du système immunitaire, qui est la défense naturelle du corps1. Certains types de chimiothérapie abaissent temporairement le nombre de globules sanguins, notamment les neutrocytes, un type de globules blancs2 chargés de lutter contre les infections. Lorsque le nombre de neutrocytes chute (phénomène de neutropénie), les risques d’infection augmentent3.

Les traitements contre le cancer contiennent souvent un stéroïde nommé dexaméthasone. Ce médicament a également le pouvoir de déprimer le système immunitaire. Les risques d’infection sont accrus par l’usage prolongé de fortes doses de médicaments immunodépresseurs, comme la dexaméthasone, ou les produits employés pour la chimiothérapie4. Les personnes âgées et celles qui étaient déjà en mauvaise santé ou se nourrissaient mal avant le traitement sont particulièrement vulnérables5. Certaines infections opportunistes sont particulièrement courantes en cas de traitement contre le cancer (p. ex. zonas et infection aux levures)6.

Conséquences sur le travail

Un employé qui suit un traitement dont on sait qu’il constitue un risque d’infection ne devrait pas travailler près de personnes malades, surtout si elles sont contagieuses, ni en contact avec le public, particulièrement à certaines périodes de l’année (p. ex. saison de la grippe). Les employés vulnérables aux infections ne doivent pas manipuler de déchets humains ou animaux. Pour réduire le risque, ils doivent disposer de toilettes ou de désinfectant pour les mains à proximité.

Étape suivante :

L’adaptation du lieu de travail en fonction des infections